Comparison of the effects of diazepam, the CRF1 antagonist CP-154,526 and the group II mGlu receptor agonist LY379268 on stress-evoked extracellular norepinephrine levels

Neuropharmacology

Volumn 48, Issue 7, 2005, Pages 927-935

  Lorrain, Daniel S ^a   Baccei, Christopher S ^a   Correa, Lucia D ^a   Bristow, Linda J ^a  

^a Merck Laboratories   (United States)

Author keywords

Anxiety; Metabotropic glutamate receptors; Microdialysis; Neurotransmitter; Norepinephrine; Stress

Indexed keywords

4 AMINO 2 OXABICYCLO[3.1.0]HEXANE 4,6 DICARBOXYLIC ACID; 4 AMINOBUTYRIC ACID B RECEPTOR STIMULATING AGENT; BACLOFEN; BUTYL[2,5 DIMETHYL 7 (2,4,6 TRIMETHYLPHENYL) 7H PYRROLO[2,3 D]PYRIMIDIN 4 YL]ETHYLAMINE; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; DIAZEPAM; METABOTROPIC RECEPTOR 2; METABOTROPIC RECEPTOR 3; METABOTROPIC RECEPTOR AGONIST; NORADRENALIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DOSE RESPONSE; EVOKED RESPONSE; GABAERGIC SYSTEM; GABAERGIC TRANSMISSION; MALE; NONHUMAN; NORADRENALIN BLOOD LEVEL; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; STRESS;

EID: 18044387193     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2004.12.022     Document Type: Article

References (45)

1. G.K. Aghajanian Tolerance of locus coeruleus neurones to morphine and suppression of withdrawal response by clonidine Nature 276 1978 186 188
2. G.K. Aghajanian, and C.P. VanderMaelen Alpha 2-adrenoceptor-mediated hyperpolarization of locus coeruleus neurons: intracellular studies in vivo Science 215 1982 1394 1396
3. T.L. Bale, and W.W. Vale CRF and CRF receptors: role in stress responsivity and other behaviors Annu. Rev. Pharmacol. Toxicol. 44 2004 525 557
4. G. Battaglia, J.A. Monn, and D.D. Schoepp In vivo inhibition of veratridine-evoked release of striatal excitatory amino acids by the group II metabotropic glutamate receptor agonist LY354740 in rats Neurosci. Lett. 229 1997 161 164
5. J.D. Bremner, J.H. Krystal, S.M. Southwick, and D.S. Charney Noradrenergic mechanisms in stress and anxiety: I. Preclinical studies Synapse 23 1996 28 38
6. J.D. Bremner, J.H. Krystal, S.M. Southwick, and D.S. Charney Noradrenergic mechanisms in stress and anxiety: II. Clinical studies Synapse 23 1996 39 51
7. J. Cartmell, and D.D. Schoepp Regulation of neurotransmitter release by metabotropic glutamate receptors J. Neurochem. 75 2000 889 907
8. P.J. Conn, and J.P. Pin Pharmacology and functions of metabotropic glutamate receptors Annu. Rev. Pharmacol. Toxicol. 37 1997 205 237
9. C.L. Cox, and S.M. Sherman Glutamate inhibits thalamic reticular neurons J. Neurosci. 19 1999 6694 6699
10. A.L. Curtis, S.M. Lechner, L.A. Pavcovich, and R.J. Valentino Activation of the locus coeruleus noradrenergic system by intracoerulear microinfusion of corticotropin-releasing factor: effects on discharge rate, cortical norepinephrine levels and cortical electroencephalographic activity J. Pharmacol. Exp. Ther. 281 1997 163 172
11. J.W. Dalley, K. Mason, and S.C. Stanford Increased levels of extracellular noradrenaline in the frontal cortex of rats exposed to naturalistic environmental stimuli: modulation by acute systemic administration of diazepam or buspirone Psychopharmacology (Berl.) 127 1996 47 54
12. L. Dazzi, E. Seu, G. Cherchi, and G. Biggio Antagonism of the stress-induced increase in cortical norepinephrine output by the selective norepinephrine reuptake inhibitor reboxetine Eur. J. Pharmacol. 476 2003 55 61
13. R.C. Drugan, S.M. Ryan, T.R. Minor, and S.F. Maier Librium prevents the analgesia and shuttlebox escape deficit typically observed following inescapable shock Pharmacol. Biochem. Behav. 21 1984 749 754
14. H. Emoto, C. Koga, H. Ishii, H. Yokoo, M. Yoshida, and M. Tanaka A CRF antagonist attenuates stress-induced increases in NA turnover in extended brain regions in rats Brain Res. 627 1993 171 176
15. H. Emoto, H. Yokoo, M. Yoshida, and M. Tanaka Corticotropin-releasing factor enhances noradrenaline release in the rat hypothalamus assessed by intracerebral microdialysis Brain Res. 601 1993 286 288
16. P. Ferris, E. Seward, and G.R. Dawson Interactions between LY354740, a group II metabotropic agonist and the GABA(A)-benzodiazepine receptor complex in the rat elevated plus-maze J. Psychopharmacol. 15 2001 76 82
17. J.M. Finlay, M.J. Zigmond, and E.D. Abercrombie Increased dopamine and norepinephrine release in medial prefrontal cortex induced by acute and chronic stress: effects of diazepam Neuroscience 64 1995 619 628
18. M.M. Grant, and J.M. Weiss Effects of chronic antidepressant drug administration and electroconvulsive shock on locus coeruleus electrophysiologic activity Biol. Psychiatry 49 2001 117 129
19. G. Griebel, J. Simiand, R. Steinberg, M. Jung, D. Gully, P. Roger, M. Geslin, B. Scatton, J.P. Maffrand, and P. Soubrie 4-(2-Chloro-4-methoxy-5- methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl] 5-methyl-N-(2-propynyl)-1, 3-thiazol-2-amine hydrochloride (SSR125543A), a potent and selective corticotrophin-releasing factor(1) receptor antagonist. II. Characterization in rodent models of stress-related disorders J. Pharmacol. Exp. Ther. 301 2002 333 345
20. C. Grillon, J. Cordova, L.R. Levine, and C.A. Morgan 3rd Anxiolytic effects of a novel group II metabotropic glutamate receptor agonist (LY354740) in the fear-potentiated startle paradigm in humans Psychopharmacology (Berl.) 168 2003 446 454
21. D.R. Helton, J.P. Tizzano, J.A. Monn, D.D. Schoepp, and M.J. Kallman Anxiolytic and side-effect profile of LY354740: a potent, highly selective, orally active agonist for group II metabotropic glutamate receptors J. Pharmacol. Exp. Ther. 284 1998 651 660
22. H. Kawahara, Y. Kawahara, and B.H. Westerink The role of afferents to the locus coeruleus in the handling stress-induced increase in the release of noradrenaline in the medial prefrontal cortex: a dual-probe microdialysis study in the rat brain Eur. J. Pharmacol. 387 2000 279 286
23. G.F. Koob Corticotropin-releasing factor, norepinephrine, and stress Biol. Psychiatry 46 1999 1167 1180
24. D.S. Lorrain, C.S. Baccei, L.J. Bristow, J.J. Anderson, and M.A. Varney Effects of ketamine and N-methyl-d-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268 Neuroscience 117 2003 697 706
25. D.S. Lorrain, H. Schaffhauser, U.C. Campbell, C.S. Baccei, L.D. Correa, B. Rowe, D.E. Rodriguez, J.J. Anderson, M.A. Varney, A.B. Pinkerton, J.M. Vernier, and L.J. Bristow Group II mGlu receptor activation suppresses norepinephrine release in the ventral hippocampus and locomotor responses to acute ketamine challenge Neuropsychopharmacology 28 2003 1622 1632
26. B. Moghaddam Stress preferentially increases extraneuronal levels of excitatory amino acids in the prefrontal cortex: comparison to hippocampus and basal ganglia J. Neurochem. 60 1993 1650 1657
27. B. Moghaddam, and B.W. Adams Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats Science 281 1998 1349 1352
28. J.A. Monn, M.J. Valli, S.M. Massey, M.M. Hansen, T.J. Kress, J.P. Wepsiec, A.R. Harkness, J.L. Grutsch Jr., R.A. Wright, B.G. Johnson, S.L. Andis, A. Kingston, R. Tomlinson, R. Lewis, K.R. Griffey, J.P. Tizzano, and D.D. Schoepp Synthesis, pharmacological characterization, and molecular modeling of heterobicyclic amino acids related to (+)-2-aminobicyclo[3.1.0] hexane-2,6-dicarboxylic acid (LY354740): identification of two new potent, selective, and systemically active agonists for group II metabotropic glutamate receptors J. Med. Chem. 42 1999 1027 1040
29. J.A. Monn, M.J. Valli, S.M. Massey, R.A. Wright, C.R. Salhoff, B.G. Johnson, T. Howe, C.A. Alt, G.A. Rhodes, R.L. Robey, K.R. Griffey, J.P. Tizzano, M.J. Kallman, D.R. Helton, and D.D. Schoepp Design, synthesis, and pharmacological characterization of (+)-2-aminobicyclo[3.1.0]hexane-2,6- dicarboxylic acid (LY354740): a potent, selective, and orally active group 2 metabotropic glutamate receptor agonist possessing anticonvulsant and anxiolytic properties J. Med. Chem. 40 1997 528 537
30. H. Nakane, N. Shimizu, and T. Hori Stress-induced norepinephrine release in the rat prefrontal cortex measured by microdialysis Am. J. Physiol. 267 1994 R1559 R1566
31. G. Paxinos, and C. Watson The rat brain in stereotaxic coordinates fourth ed. 1998 Academic Press
32. K. Rasmussen, and B.L. Jacobs Single unit activity of locus coeruleus neurons in the freely moving cat. II. Conditioning and pharmacologic studies Brain Res. 371 1986 335 344
33. D.E. Redmond Jr., and Y.H. Huang Current concepts. II. New evidence for a locus coeruleus-norepinephrine connection with anxiety Life Sci. 25 1979 2149 2162
34. D.D. Schoepp Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system J. Pharmacol. Exp. Ther. 299 2001 12 20
35. D.D. Schoepp, R.A. Wright, L.R. Levine, B. Gaydos, and W.Z. Potter LY354740, an mGlu2/3 receptor agonist as a novel approach to treat anxiety/stress Stress 6 2003 189 197
36. C. Schulz, and H. Lehnert Activation of noradrenergic neurons in the locus coeruleus by corticotropin-releasing factor. A microdialysis study Neuroendocrinology 63 1996 454 458
37. A. Shekhar, and S.R. Keim LY354740, a potent group II metabotropic glutamate receptor agonist prevents lactate-induced panic-like response in panic-prone rats Neuropharmacology 39 2000 1139 1146
38. N. Shimizu, H. Nakane, T. Hori, and Y. Hayashi CRF receptor antagonist attenuates stress-induced noradrenaline release in the medial prefrontal cortex of rats Brain Res. 654 1994 145 148
39. I. Smolders, H. Lindekens, R. Clinckers, A. Meurs, M.J. O'Neill, D. Lodge, G. Ebinger, and Y. Michotte In vivo modulation of extracellular hippocampal glutamate and GABA levels and limbic seizures by group I and II metabotropic glutamate receptor ligands J. Neurochem. 88 2004 1068 1077
40. C.J. Swanson, K.W. Perry, and D.D. Schoepp The mGlu2/3 receptor agonist, LY354740, blocks immobilization-induced increases in noradrenaline and dopamine release in the rat medial prefrontal cortex J. Neurochem. 88 2004 194 202
41. S.T. Szabo, and P. Blier Effect of the selective noradrenergic reuptake inhibitor reboxetine on the firing activity of noradrenaline and serotonin neurons Eur. J. Neurosci. 13 2001 2077 2087
42. S.T. Szabo, C. de Montigny, and P. Blier Progressive attenuation of the firing activity of locus coeruleus noradrenergic neurons by sustained administration of selective serotonin reuptake inhibitors Int. J. Neuropsychopharmacol. 3 2000 1 11
43. M. Tanaka, A. Tsuda, H. Yokoo, M. Yoshida, Y. Ida, and H. Nishimura Involvement of the brain noradrenaline system in emotional changes caused by stress in rats Ann. N. Y. Acad. Sci. 597 1990 159 174
44. J.P. Tizzano, K.I. Griffey, and D.D. Schoepp The anxiolytic action of mGlu2/3 receptor agonist, LY354740, in the fear-potentiated startle model in rats is mechanistically distinct from diazepam Pharmacol. Biochem. Behav. 73 2002 367 374
45. J. Zhao, E. Ramadan, M. Cappiello, B. Wroblewska, T. Bzdega, and J.H. Neale NAAG inhibits KCl-induced [(3)H]-GABA release via mGluR3, cAMP, PKA and L-type calcium conductance Eur. J. Neurosci. 13 2001 340 346